|1.||Nishi, Masahiro: 2 articles (11/2011 - 09/2004)|
|2.||Hamanishi, Tohru: 2 articles (11/2011 - 09/2004)|
|3.||Doi, Asako: 2 articles (11/2011 - 09/2004)|
|4.||Sasaki, Hideyuki: 2 articles (11/2011 - 09/2004)|
|5.||Nanjo, Kishio: 2 articles (11/2011 - 09/2004)|
|6.||Furuta, Hiroto: 2 articles (11/2011 - 09/2004)|
|7.||Farajollahi, Mohammad: 1 article (12/2014)|
|8.||Najafi, Mohammad: 1 article (12/2014)|
|9.||Roustazadeh, Abazar: 1 article (12/2014)|
|10.||Ghasemi, Hassan: 1 article (12/2014)|
|1.||Hyaline Membrane Disease
10/01/2012 - "The phosphopeptide Pro-Leu-His-Ser-p-Thr (PLHSpT) is a potent selective inhibitor of the PBD of human plk1 that acts by inducing mitotic arrest and apoptotic cell death in cancer cells. "
10/01/2011 - "Overall, the results indicated that individuals who carried variant Leu allele (Pro/Leu and Leu/Leu) were associated with an increased cancer risk [odds ratio (OR) = 1.12, 95% confidence interval (CI) = 1.02-1.23] in a dominant genetic model. "
05/01/2005 - "A nonconservative Pro/Leu nucleotide polymorphism within PTCH exon 23 at codon 1315 was recently reported to be potentially important for the development of breast epithelial cell cancers. "
11/01/2004 - "Tumor DNAs exhibited fewer pro/leu heterozygotes as compared to DNA obtained from the cancer-free population. "
08/01/2004 - "Compared with the Pro/Pro genotype the Pro/Leu genotype was significantly associated with advanced tumor stage (Ta-1 vs T2-4, OR 2.58, 95% CI 1.07 to 6.18, p = 0.034) but not with tumor grade. "
|4.||Lung Neoplasms (Lung Cancer)
03/01/2006 - "Individuals carrying the Pro/Leu or Leu/Leu genotype of GPX1 were at a higher risk for lung cancer (adjusted OR = 2.29). "
03/13/1997 - "In 37 lung cancer cell lines we found: an allelic variant in MEK-1 cDNA, nt 783 G-->A, (no amino acid change); a MEK-2 cDNA change (nt 977 C-->T mutation leading to 298 Pro-->Leu change); a MEK-2 cDNA change nt 537 C-->T (no amino acid change); and a frequent MEK-2 cDNA germline polymorphism nt 744, A-->C (no amino acid change) with an allele frequency of 0.5 for each form. "
03/01/2006 - "These results lead to a conclusion that individuals with the GPX1 Pro/Leu or Leu/Leu genotype would be more susceptible to the lung cancer induced by oxidative stress than those individuals with the Pro/Pro genotype."
|5.||Breast Neoplasms (Breast Cancer)
10/01/2007 - "The Pro/Leu polymorphism in germline is associated with a higher risk for breast cancer, but a potential contribution to the tumorigenesis of trichoblastoma is unknown. "
01/01/2002 - "Similarly, treatment with B[a]P, TCDD, or BPDE failed to repress transcription from the pGL3-BRCA-1 construct transfected into ZR75.1 breast cancer cells containing mutated p53 ((152)Pro-->Leu). "
|5.||3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamide
|7.||Thrombin Receptors (Thrombin Receptor)
|8.||Complementary DNA (cDNA)
|9.||Dopamine D2 Receptors (Dopamine D2 Receptor)
|10.||Prostate-Specific Antigen (Semenogelase)